{
    "Variants Include": [
        {
            "Gene": "LRRK2",
            "variants": [
                {
                    "HGVS": "NM_198578.4:c.2019G>A",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "2019"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "S",
                        "position": "2019"
                    },
                    "Description in input context": "G2019S"
                },
                {
                    "HGVS": "NM_198578.4:c.2020T>C",
                    "cDNA Change": {
                        "transcript": "NM_198578.4",
                        "ref": "T",
                        "alt": "C",
                        "position": "2020"
                    },
                    "Protein Change": {
                        "ref": "I",
                        "alt": "T",
                        "position": "2020"
                    },
                    "Description in input context": "I2020T"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson’s disease",
        "MONDO": "MONDO:0005586"
    },
    "Experiment Method": [
        {
            "Assay Method": "TR-FRET competitive binding assay",
            "Material used": {
                "Material Source": "Protein",
                "Material Name": "LRRK2 (amino acids 970–2527) wild-type, G2019S, and I2020T",
                "Description": "N-terminal GST-tagged LRRK2 (amino acids 970–2527) wild-type, G2019S, and I2020T were from Invitrogen Corporation."
            },
            "Readout type": "Binding Affinity",
            "Readout description": [
                {
                    "Variant": "NM_198578.4:c.2019G>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "G2019S and I2020T have approximately 2-fold lower and 6-fold higher ATP affinity, respectively, than wild-type LRRK2."
                },
                {
                    "Variant": "NM_198578.4:c.2020T>C",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "I2020T has an approximately 9-fold higher affinity for ATP, whereas the ATP affinity of G2019S is about 2-fold lower than wild-type LRRK2."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "All assays were performed using either three or four replicates for each data point represented."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Radiometric kinase activity assays",
            "Material used": {
                "Material Source": "Protein",
                "Material Name": "LRRK2 (amino acids 970–2527) wild-type, G2019S, and I2020T",
                "Description": "N-terminal GST-tagged LRRK2 (amino acids 970–2527) wild-type, G2019S, and I2020T were from Invitrogen Corporation."
            },
            "Readout type": "Kinase Activity",
            "Readout description": [
                {
                    "Variant": "NM_198578.4:c.2019G>A",
                    "Conclusion": "G2019S is 1.6-fold more sensitive to ATP-competitive kinase inhibitors than wild-type LRRK2.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "G2019S was modestly more sensitive to inhibition than wild-type LRRK2 with an IC50 value of 230 nM."
                },
                {
                    "Variant": "NM_198578.4:c.2020T>C",
                    "Conclusion": "I2020T is approximately 10-fold more resistant to ATP-competitive kinase inhibitors than wild-type.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "I2020T was incompletely inhibited and had an IC50 value of at least 5 lM."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "All assays were performed using either three or four replicates for each data point represented."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}